The company failed to achieve the necessary quorum for its scheduled shareholder meeting on June 9, 2026. The meeting has been officially adjourned and rescheduled for June 16, 2026, at 10:00 a.m. EST. Shareholders are directed to access the meeting via the previously provided link at www.colonialstock.com/AspireBiopharma2026.